18 results
10-K
2024 FY
EX-97.1
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
”) of the Company believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
to induce an inflammatory response. The inflammatory response was assessed by measuring cytokine levels in the culture medium after 24 hours
S-1
IXHL
Incannex Healthcare Limited
3 Jul 24
IPO registration
6:29am
was assessed by measuring cytokine levels in the culture medium after 24 hours. A reduction in cytokine levels in response to drug treatment is indicative
8-K
EX-14.1
IXHL
Incannex Healthcare Limited
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
guidance to help them recognize and deal with ethical issues, provide mechanisms to report unethical conduct and foster a culture of honesty
6-K
EX-99.1
xnwu3tft3o7 tr073i
1 Sep 23
Report of Foreign Private Issuer
8:43am
6-K
EX-99.1
x6priod4
1 Sep 23
Report of Foreign Private Issuer
12:00am
20-F
15940l9kp0kng ch4
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
ye1avshc 27pz4
19 Sep 22
Report of Foreign Private Issuer
9:38pm
6-K
EX-99.1
16ao ojrnnvdl5e5z
12 May 22
Report of Foreign Private Issuer
9:25am
20FR12B/A
vb6ho b6t9
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
hhdn gikyqcfq9lp
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am
20FR12B
78tssi8b9uukxcv
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
F-1/A
wjd1wo
7 Dec 21
Registration statement (foreign) (amended)
5:21pm
F-1/A
j2fz2xmknr62dx 1s7p6
23 Nov 21
Registration statement (foreign) (amended)
3:28pm
F-1/A
n4gdx2z8n17
3 Nov 21
Registration statement (foreign) (amended)
6:06am
F-1/A
dql5 2lq9
28 Sep 21
Registration statement (foreign) (amended)
6:06am
F-1
xtblmv1yr85
17 Aug 21
Registration statement (foreign)
4:39pm
- Prev
- 1
- Next